Fortress Biotech, Inc. - May 16, 2024 Form 3 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
10%+ Owner
Signature
/s/ Lindsay A. Rosenwald, M.D. Chairman, President and Chief Executive Officer
Stock symbol
CKPT
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
3
Date filed
5/24/2024, 04:05 PM
Previous filing
Apr 17, 2024
Next filing
Jun 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CKPT COMMON STOCK, PAR VALUE $0.0001 3.59M May 16, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CKPT CLASS A COMMON STOCK, PAR VALUE $0.0001 May 16, 2024 Common Stock 700K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Class A Common Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.